Ecnoglutide
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
Hangzhou Sciwind Biosciences Co · Phase 1/2 · Recruiting · Enrollment 126
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| oral ecnoglutide dose 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| oral ecnoglutide dose 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| oral ecnoglutide dose 3 | Obesity or overweight | n/r | n/r | n/r | n/r |
| oral ecnoglutide dose 4 | Obesity or overweight | n/r | n/r | n/r | n/r |
| placebo dose 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| placebo dose 2 | Obesity or overweight | n/r | n/r | n/r | n/r |